Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171998 | SCV000054757 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000038741 | SCV000062419 | likely benign | not specified | 2015-06-11 | criteria provided, single submitter | clinical testing | p.Ile558Val in exon 9 of LDB3: This variant is not expected to have clinical sig nificance because it has been identified in 0.3% (40/12734) South Asian chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs372331627). |
Gene |
RCV000171998 | SCV000236009 | benign | not provided | 2020-09-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25179549, 24503780, 26112015, 27896284, 20474083, 25351510, 27633507, 27884173, 30315573, 31127727) |
Center for Advanced Laboratory Medicine, |
RCV000852622 | SCV000995326 | likely benign | Arrhythmogenic right ventricular cardiomyopathy | 2019-03-18 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988404 | SCV001138109 | benign | Myofibrillar myopathy 4 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170179 | SCV001332729 | benign | Cardiomyopathy | 2017-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000988404 | SCV002372738 | benign | Myofibrillar myopathy 4 | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399380 | SCV002708526 | likely benign | Cardiovascular phenotype | 2020-09-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000171998 | SCV004127016 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | LDB3: BS1 |
Clinical Genetics, |
RCV000171998 | SCV001925714 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000171998 | SCV001953608 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000171998 | SCV001965907 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000171998 | SCV002034882 | uncertain significance | not provided | no assertion criteria provided | clinical testing |